ACHE and Alzheimer disease: Hwang et al. [221] developed a reduced graphene oxide-based enzyme-modified FET (RGO-EnFET) to study acetylcholinesterase enzyme kinetics and the impact of acetylcholinesterase inhibitors on AD therapy.